1/30
09:03 am
xgn
Exagen (NASDAQ:XGN) had its "buy" rating reaffirmed by analysts at B. Riley. They now have a $8.00 price target on the stock, down previously from $18.00.
Medium
Report
Exagen (NASDAQ:XGN) had its "buy" rating reaffirmed by analysts at B. Riley. They now have a $8.00 price target on the stock, down previously from $18.00.
1/27
05:32 pm
xgn
How The Exagen (XGN) Story Is Shifting With A New Analyst Price Target [Yahoo! Finance]
Medium
Report
How The Exagen (XGN) Story Is Shifting With A New Analyst Price Target [Yahoo! Finance]
1/12
01:38 pm
xgn
How Recent Analyst Resets Are Reframing The Exagen (XGN) Investment Story [Yahoo! Finance]
Low
Report
How Recent Analyst Resets Are Reframing The Exagen (XGN) Investment Story [Yahoo! Finance]
1/11
03:18 pm
xgn
Exagen Inc. Announces Select Preliminary 2025 Financial Results [Yahoo! Finance]
Medium
Report
Exagen Inc. Announces Select Preliminary 2025 Financial Results [Yahoo! Finance]
1/11
03:00 pm
xgn
Exagen Inc. Announces Select Preliminary 2025 Financial Results
Medium
Report
Exagen Inc. Announces Select Preliminary 2025 Financial Results
12/22
02:32 am
xgn
How the Narrative Surrounding Exagen Is Evolving After New Guidance and Price Target Upgrades [Yahoo! Finance]
Medium
Report
How the Narrative Surrounding Exagen Is Evolving After New Guidance and Price Target Upgrades [Yahoo! Finance]